Form 4: Unity Biotechnology CFO Lynne Sullivan Sells Shares to Cover Tax Obligations

Lynne Marie Sullivan, CFO of Unity Biotechnology, sold 153 shares of common stock on February 4, 2025, to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• On February 4, 2025, Lynne Marie Sullivan, the CFO and Head of Corporate Development of Unity Biotechnology, sold 153 shares of the company's common stock.
• The sale was executed at a price of $2.23 per share.
• The transaction was conducted under a Rule 10b5-1 trading plan.
• The purpose of the sale was to cover tax withholding obligations arising from the vesting of Restricted Stock Units (RSUs).
• Following the transaction, Sullivan directly owns 55,772 shares, which includes unvested Restricted Stock Units.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing simply reports a routine stock sale for tax purposes. It doesn't indicate any positive or negative outlook for the company.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating it was planned and not based on immediate market conditions.

Industry Context

Sales of shares by company executives are a normal part of corporate governance. It is common for executives to sell shares to cover tax obligations related to vesting equity awards.

Stakeholder Impact

• The sale is unlikely to have a significant impact on stakeholders as it is a small transaction related to tax obligations.

Key Dates

Keywords

Form 4, Unity Biotechnology, UBX, Lynne Sullivan, CFO, stock sale, Rule 10b5-1, Restricted Stock Units, tax withholding